Yükleniyor

Yayın ve Akademik Faaliyet Özeti

32
Makale
52
Atıf
8
Bildiri
2
Ödül
1
Tez
İndekslere Göre Yayın Sayıları
4 indeks
23
SCI-E
4
Diğer
4
ESCI
3
TR Dizin
Makale Bilgileri
1
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature, Clinical Genitourinary Cancer, 24(0), 2026 SCI / SCI EXPANDED
Cevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, Mert Başaran, Nur Şener
2
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors, JCO Global Oncology, 12(0), 2026 ESCI
Doç. Dr. Mustafa Gürbüz, Deniz Tural, Timuçin Çil, Hacer Demir, Osman Köstek
3
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI?SAFRADJU?2501), INTERNATIONAL JOURNAL OF CANCER, 159(0), 2026 SCI / SCI EXPANDED
Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu, Ilgın Koç Kuş, Doğan Bayram
4
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO), JCO Global Oncology, 12(0), 2026 ESCI
Erman Akkus, Mehmet Kayaalp, Muzeyyen Aslı Ergozoglu, Ilgın Koç Kus¸ Dogan Bayram, Bilgesah Kılıçtas¸ Emel Ayvaz Guneyin
5
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma, Medicina-Lithuania, 61(0), 2025 SCI / SCI EXPANDED
Ali Alper Solmaz, Ilhan Birsenogul, Aygul Polat Kelle, Pinar Peker, Burcu Arslan Benli
6
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI, Biomarkers in Medicine, 19(17), 2025 SCI / SCI EXPANDED
Ali Ogul, Ali Alper Solmaz, Ilhan Birsenogul, Yunus Coskun, Mahmut Bakır Koyuncu
7
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer, Scientific Reports, 15(0), 2025 SCI / SCI EXPANDED
Yasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, Muslih Ürün, Berrak Mermit Erçek
8
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis from the Turkish Oncology Group, Clinical Lung Cancer, 26(8), 2025 SCI / SCI EXPANDED
Tuğba Akın Telli, Ali Murat Tatlı, Özkan Alan, Gülsema Yıldıran Keskin, Nuri Karadurmuş
9
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis, BMC CANCER, 25(0), 2025 SCI / SCI EXPANDED
Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu
10
11
Rectal Cancer and Lateral Lymph Node Staging: Interobserver Agreement and Success in Predicting Locoregional Recurrence, Diagnostics, 14(22), 2024 SCI / SCI EXPANDED
Hüseyin Akkaya, Okan Dilek, Selim Özdemir, Turgay Öztürkçü, Doç. Dr. Mustafa Gürbüz
12
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing, JOURNAL OF CHEMOTHERAPY, 36(0), 2024 SCI / SCI EXPANDED
Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, Didem Tastekin, Senem Karabulut
13
Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer, Journal of Cancer Research and Therapeutics, 19(0), 2023 SCI / SCI EXPANDED
İzzet Doğan, Doç. Dr. Mustafa Gürbüz, Esra Aydın, Senem Karabulut, Didem Taştekin
14
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers, Balkan Journal of Medical Genetics, 25(0), 2023 SCI / SCI EXPANDED
Osman Köstek, Ahmet Küçükarda, Hilmi Tozkır, İlker Nihat Ökten, Ercan Özden
15
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(0), 2022 SCI / SCI EXPANDED
Doç. Dr. Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse
16
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study, MEDICINE, 101(0), 2022 SCI / SCI EXPANDED
İzzet Doğan, Murat Ayhan, Doç. Dr. Mustafa Gürbüz, Ahmet Kucukarda, Esra Aydın
17
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group, MEDICINE, 101(50), 2022 SCI / SCI EXPANDED
Doç. Dr. Mustafa Gürbüz, Saadettin Kılıçkap, Ahmet Bilici, Nuri Karadurmuş, Ahmet Sezer
18
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(6), 2022 SCI / SCI EXPANDED
Mutlu Hızal, Burak Bilgin, Nail Paksoy, Özgür Açıkgöz, Ahmet Sezer
19
Clinicopathological Factors in Relation to HER2 Status in Metastatic Gastric Cancer: A Retrospective Observational Study, JOURNAL of ONCOLOGICAL SCIENCES, 8(0), 2022 Diğer
Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, İbrahim Karadağ, Serdar Karakaya
20
Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC, MEDICINE, 101(0), 2022 SCI / SCI EXPANDED
İzzet Doğan, Doç. Dr. Mustafa Gürbüz, Nail Paksoy, Ferhat Ferhatoğlu, Sezai Vatansever
21
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group, Journal of Gastric Cancer, 53(0), 2022 ESCI
Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray
22
The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer, Tuberkuloz ve Toraks-Tuberculosis and Thorax, 70(0), 2022 ESCI
Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hilal Özakıncı, Pınar Kubilay Tolunay
23
Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients, Journal of Mens Health, 17(0), 2021 SCI / SCI EXPANDED
Ali Alkan, Zeynep Gülsüm Güç, Doç. Dr. Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu
24
Association Between Blood Type and Epidermal Growth Factor Receptor Mutation Positivity in Lung Adenocarcinoma Patients, JOURNAL of ONCOLOGICAL SCIENCES, 7(0), 2021 ULAKBİM TR DİZİN
Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Bilgin Karaalioğlu, Elif Gizem Aktaş, Elif Berna Köksoy
25
Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study, JOURNAL of ONCOLOGICAL SCIENCES, 7(0), 2021 ULAKBİM TR DİZİN
Emre Yekedüz, Elif Berna Köksoy, Satı Coşkun Yazgan, Ilgın Akbıyık, Sevinç Ballı
26
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer, Tumori Journal, 107(0), 2021 SCI / SCI EXPANDED
Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray
27
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data, journal of buon, 26(0), 2021 Diğer
Öztürk Ateş, Ömür Berna Öksüzoğlu, Burak Yasin Aktaş, İbrahim Karadağ, Selin Esen
28
Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data, Dermatologic Therapy, 34(0), 2021 SCI / SCI EXPANDED
Doç. Dr. Mustafa Gürbüz, İzzet Doğan, Erman Akkuş, Hande Ermiş, Güngör Utkan
29
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(0), 2021 SCI / SCI EXPANDED
Burak Bilgin, Mehmet Ali Nahit Sendur, Sebnem Yucel, Emir Celik, Deniz Tataroglu Ozyukseler
30
31
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG), EUROPEAN JOURNAL OF CANCER CARE, 29(0), 2020 SCI / SCI EXPANDED
Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, Doç. Dr. Mustafa Gürbüz, Tuğba Başoğlu
32
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey, jbuon, 25(4), 2020 Diğer
Muhammet Bekir Hacıoğlu, Osman Kostek, Senem Karabulut, Didem Tastekin, Sema Sezgin Goksu
1
PROSTAT KANSERİNDE ANDROJEN RESEPTÖR VARYASYONUNUN (AR-V7) KLİNİK ÖNEMİ
XII. Ulusal Haseki Tıp Kongresi · 01.09.2022
Doç. Dr. Mustafa Gürbüz, Yaşar Sertdemir, Emine Kılıç Bağır, Şeyda Erdoğan, Berksoy Şahin
2
MİDE VE GASTROÖZOFAGEAL BİLEŞKE KANSERLERİNDE PERİOPERATİF FLOT KEMOTERAPİSİ TEK MERKEZ DENEYİMİ
1. ÇUKUROVA İÇ HASTALIKLARI GÜNLERİ · 27.05.2022
Doç. Dr. Mustafa Gürbüz
3
İLERİ EVRE MİDE KANSERİNDE MULTİDEDEKTÖR BİLGİSAYARLI TOMOGRAFİDE ASİT VARLIĞININ ÖNEMİ
4. ULUSLARARASI TIP BİLİMLERİ VE MULTİDİSİPLİNER YAKLAŞIMLAR KONGRESİ · 26.03.2022
Doç. Dr. Mustafa Gürbüz, Özlem Akıncı
4
PDL-1 TESTİ YAPILAN KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERLİLERİN (KHDAK) ÇOK MERKEZLİ TÜRKİYE GERÇEK YAŞAM KLİNİK SONUÇLARI
8. Türk Tıbbi Onkoloji Kongresi · 03.11.2021
Ozan Yazıcı, Fatih Gürler, Ramazan Acar, Doç. Dr. Mustafa Gürbüz, Deniz Can Güven
5
KANSER HASTALARINDA HBV, HCV, HİV SIKLIĞI İLİŞKİLİ FAKTÖRLERİN SAPTANMASI
TÜRK TIBBİ ONKOLOJİ DERNEĞİ SANAL KONGRESİ · 12.11.2020
Doç. Dr. Mustafa Gürbüz, Deniz Tural, Timuçin Çil, Hacer Demir, Osman Köstek
6
KASTRASYON DİRENÇLİ PROSTAT KANSERİNDE KABAZİTAKSEL: TEK MERKEZ DENEYİMİ
3. Muğla Multidisipliner Onkolojik Araştırmalar Kongresi · 18.10.2019
Doç. Dr. Mustafa Gürbüz, Erman Akkuş, Yüksel Ürün
7
Colchicine and serum CA72-4 elevation
10th Eurasian Hematology Oncology Congress · 08.10.2019
Doç. Dr. Mustafa Gürbüz, Durmuş Eralp Tutar, Pınar Kubilay Tolunay, Bilgin Karaalioğlu, Emre Yekedüz
8
Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçlari- Gerçek Yaşam Verisi
23. Ulusal Kanser Kongresi · 17.04.2019
Ali Alkan, Zeynep Sevgen Güç, Doç. Dr. Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu
1
En İyi Sözel Bildiri Ödülü, 03.11.2021
8. Türk Tıbbi Onkoloji Kongresi
2
En İyi Sözel Bildiri Ödülü, 14.11.2020
Türk Tıbbi Onkoloji Derneği Sanal Kongresi
1
Prostat kanserinde androjen reseptör varyasyonunun (AR-V7) klinik önemi
Uzmanlık · 2016
↑